Daiichi Sankyo
NJ · 12 filings, 2025
Lobbying spend · 2025
$780K
to shape legislation
About the organization
Daiichi Sankyo Company, Limited (Japanese: 第一三共株式会社, Hepburn: Daiichi Sankyō Kabushiki-gaisha) is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Taxation/Internal Revenue Code · Medicare/Medicaid
2Through these firms · 3
TIBER CREEK GROUPDAIICHI SANKYO, INC.FARRAGUT PARTNERS LLP
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5236A bill to amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services…
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5227A bill to amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified t…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…